Today's Change
+1.5%
AI Sentiment
56%
Sector AnalysisLive data
Healthcare Sector Outlook
The Healthcare sector is up 1.5% today with neutral sentiment across 5 recent news articles. Top movers include $COR (+3.58%), $BDX (+3.39%), $ABT (+3.35%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Healthcare
21 stocks| Symbol | Company | Change |
|---|---|---|
| $ABBV | AbbVie Inc. | +2.12% |
| $AMGN | Amgen Inc. | +0.85% |
| $ABT | Abbott Laboratories | +3.35% |
| $DHR | Danaher Corporation | -0.15% |
| $BMY | Bristol-Myers Squibb Company | +1.70% |
| $ELV | Elevance Health Inc. | +0.08% |
| $CI | The Cigna Group | +0.04% |
| $BSX | Boston Scientific Corporation | +2.39% |
| $COR | Cencora Inc. | +3.58% |
| $CAH | Cardinal Health Inc. | +1.79% |
| $EW | Edwards Lifesciences Corporation | +0.52% |
| $BDX | Becton Dickinson and Company | +3.39% |
| $A | Agilent Technologies Inc. | +0.73% |
| $ZTS | Zoetis Inc. | +1.16% |
| $CNC | Centene Corporation | +0.05% |
Healthcare News
716 articlesGlobeNewswire Inc.89d ago
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
The Motley Fool89d ago
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale
GlobeNewswire Inc.90d ago
Bronstein, Gewirtz & Grossman LLC Urges Lakeland Industries, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Benzinga90d ago
Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst
Benzinga90d ago
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks
GlobeNewswire Inc.90d ago
Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”
Benzinga90d ago
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
Benzinga90d ago
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
The Motley Fool90d ago
A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story
Market Sentiment
Neutral
56% Sentiment Score
Sector Stats
Total Stocks21
News Today5
Avg Volume5.2M
AI SentimentNeutral